Delivery Order SPE2DB22D1017-SPE2DB25FF2HT

Award Date 12/31/24
Potential Completion Date 1/2/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2HT
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FF2HT, is for the procurement of GARDASIL 9 vaccine syringes (0.5 mL) by the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,164.69 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order contract with a firm fixed price pricing type and has an ultimate completion date of January 2, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/1/25, 9:53 AM